ITMCTR2000004105招募中未知
Innovative research on the pathogenesis of myasthenia gravis in traditional Chinese medicine (N-of-1)
The First Affiliated Hospital of Guangzhou University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 65(—)
- 性别
- All
入选标准
- •1) Patients aged between 18 to 65 years;
- •2) Patients diagnosed with MG based on The Chinese guidelines for the diagnosis and treatment of myasthenia gravis (2020): patients with typical clinical features of MG (fluctuating myasthenia) excluded from other diseases and meeting any of the following three points, including pharmacological examination, electrophysiological characteristics or serum antibody detection;
- •3) Patients attached to the spleen-stomach deficiency syndrome or spleen-kidney deficiency syndrome will be enrolled which is based on The guidelines for clinical diagnosis and treatment of internal medicine of traditional Chinese Medicine: myasthenia gravis (2020);
- •4) Patients identified as class II or III according to myasthenia gravis foundation of America (MGFA) clinical classification and are in the stable stage of MG at least 3 months;
- •5) Patients with Quantitative Myasthenia Gravis (QMG) score more than 6;
- •6) Patients treated with glucocorticoid administration should not take more than 15mg prednisone (or an equivalent dose of other glucocorticoids) per day.
排除标准
- •1) Female patients who are pregnant or lactating or have a pregnancy plan during the trial;
- •2) Patients with other autoimmune diseases (e.g., polymyositis, multiple sclerosis, rheumatoid arthritis) that may impact the assessment and treatment;
- •3) Patients with severe heart, kidney, liver, lung, hematological system, infectious diseases or cancer;
- •4) Patients with neuropsychiatric disorders that cannot cooperate;
- •5) Patients received plasma exchange, glucocorticoid or gamma-globin pulse therapy within 3 months;
- •6) Patients received thymectomy within half a year;
- •8) Patients participating in other trials;
- •9) Patients consumed antibiotics, probiotics or anti-acids during the previous two months.
研究者
相似试验
尚未招募
1 期
Innovative research for the pathogenesis of myasthenia gravis in traditional Chinese medicinemyasthenia gravisITMCTR2000003226The First Affiliated Hospital of Guangzhou University of TCM
招募中
1 期
A Real World Study on Modified Danzhu Fuyuan Granule for Treatment of Vascular Dementia with Phlegm and Blood StasisVascular DementiaITMCTR2100004261Hubei University of Chinese Medicine
招募中
不适用
Elucidation of the molecular pathogenesis of myasthenia gravis using single-cell RNA analysis.Myasthenia gravisJPRN-UMIN000047407Chiba University20
进行中(未招募)
不适用
An observational longitudinal study of congenital myasthenic syndromesISRCTN18340272Oxford University Hospitals NHS Trust50
尚未招募
Unknown
Elucidation of the pathogenesis and new diagnostic or therapeutic methods for biliary tract diseases through bile juice analysis.Bile duct cancer, primary sclerosing cholangitis, IgG4-related sclerosing cholangitis, secondary sclerosing cholangitis, bile duct stones, cholangitisJPRN-UMIN000052589agoya University Graduate School of Medicine350
